How does ichorbio compare to leading competitors?
1 - Refinement
ichorbio have made incremental improvements to the purity of their antibodies compared to those currently on the market. They have also concentrated on reducing aggregation, these changes are able to aid end users in the refinement of their animal studies, by allowing ichorbio antibodies to act with greater efficacy.
2 - Reduction
ichorbio's antibodies have the lowest endotoxin on the market which will lead to a positive impact on the wellbeing of animals. Being manufactured in an ISO9001, GMP certified facility, also ensures minimal lot-to-lot variability and improved reproducibility.
| ichorbio Low Endotoxin Antibodies | Selected Competitor Alternative | |
| Endotoxin | <1 EU/mg | <2 EU/mg |
| Purity | >95% | >95% |
| Aggregation | <5% | N/A |
| Facility | cGMP compliant, ISO Quality Standard 9001:2015 | Animal free facility |
| ichorbio Ultra-Low Endotoxin Antibodies | Selected Competitor Alternative | |
| Endotoxin | <0.5 EU/mg | <1 EU/mg |
| Purity | >98% | >95% |
| Facility | cGMP compliant, ISO Quality Standard 9001:2015 | Animal free facility |
| Pathogen Free | Tested with IDEXX BioResearch's IMPACT test | Tested with IDEXX BioResearch's IMPACT test |
